Search for dissertations about: "B-type"
Showing result 1 - 5 of 47 swedish dissertations containing the word B-type.
-
1. Preeclampsia – Studies on the Placenta and B-type Natriuretic Peptide
Abstract : Preeclampsia has several pathophysiological pathways, but the placenta has a central role. The pathophysiology appears to differ between the two subtypes – early- and late-onset preeclampsia. READ MORE
-
2. Studies on scavenger receptor class B type I and genes implicated in foam cell formation
Abstract : The risk of atherosclerosis correlates with plasma levels of low-density lipoprotein (LDL) cholesterol and is inversely correlated to plasma levels of high-density lipoprotein (HDL) cholesterol. Accumulation of oxidized LDL (oxLDL) by arterial macrophages is a key event in the development of atherosclerosis. READ MORE
-
3. Electron transport components in the halophilic archaebacterium, Halobacterium halobium : with special reference to b-type cytochromes and succinate dehydrogenase
Abstract : .... READ MORE
-
4. Relation between phases present in master alloys of the Al-Ti-B type
Abstract : .... READ MORE
-
5. Heart failure : biomarker effect and influence on quality of life
Abstract : Background and aims: Heart failure (HF) is a life threatening condition and optimal handling is necessary to reduce risk of therapy failure. The aims of this thesis were: (Paper I) to examine whether BNP (B-type natriuretic peptide)-guided HF treatment improves morbidity and mortality when compared with HF therapy implemented by a treating physician at sites experienced in managing patients with HF according to guidelines; (Paper II) to investigate how to define a responder regarding optimal cut-off level of BNP to predict death, need for hospitalisation, and worsening HF and to determine the optimal time to apply the chosen cut-off value; (Paper III) to evaluate how Health-Related Quality of Life (HR-QoL) is influenced by natriuretic peptide guiding and to study how HR-QoL is affected in responders compared to non-responders; (Paper IV) to evaluate the impact of patient age on clinical outcomes, and to evaluate the impact of duration of the HF disease on outcomes and the impact of age and HF duration on BNP concentration. READ MORE